Stage III Fallopian Tube Cancer AJCC v8

general

Stage III includes: IIIA1: T1/2, N1, M0; IIIA2: T3a, N0/N1, M0; IIIB: T3b, N0/N1, M0; IIIC: T3c, N0/N1, M0. T1: Fallopian tube cancer with tumor limited to fallopian tube(s). T2: Fallopian tube cancer with tumor involving fallopian tubes with pelvic extension below pelvic brim. T3a: Fallopian tube cancer with microscopic extrapelvic (above the pelvic brim) peritoneal involvement with or without positive retroperitoneal lymph nodes. T3b: Fallopian tube cancer with macroscopic peritoneal metastasi

74

Centers

82

Active Trials

$4.0B

Cancer Funding

Specific Cancer Types(3)

Top Centers for Stage III Fallopian Tube Cancer AJCC v8(74)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
72.2
2
High-Volume Research Center
72.2
3
High-Volume Research Center
72.2
4
NCI Comprehensive
Active Research Program
65.9
5
NCI Comprehensive
Active Research Program
65.9
665.9
7
NCI Comprehensive
Active Research Program
65.9
8
NCI Comprehensive
Active Research Program
65.9
9
NCI Comprehensive
Active Research Program
65.9
10
NCI Comprehensive
Active Research Program
65.9
11
NCI Clinical
Active Research Program
65.9
12
Active Research Program
65.9
13
Active Research Program
65.9
14
Active Research Program
65.9
1565.9
16
Active Research Program
65.9
17
Active Research Program
65.9
18
NCI Comprehensive
Active Research Program
44.5
19
NCI Comprehensive
Active Research Program
44.5
20
NCI Comprehensive
Active Research Program
44.5
21
NCI Comprehensive
Active Research Program
44.5
22
NCI Comprehensive
Active Research Program
44.5
23
NCI Comprehensive
Active Research Program
44.5
24
NCI Comprehensive
Active Research Program
44.5
25
NCI Comprehensive
Active Research Program
44.5
26
NCI Comprehensive
Active Research Program
44.5
27
NCI Comprehensive
Active Research Program
44.5
28
NCI Comprehensive
Active Research Program
44.5
29
NCI Comprehensive
Active Research Program
44.5
30
NCI Comprehensive
Active Research Program
44.5
31
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
44.5
32
NCI Comprehensive
Active Research Program
44.5
33
NCI Comprehensive
Active Research Program
44.5
34
NCI Comprehensive
Active Research Program
44.5
35
NCI Comprehensive
Active Research Program
44.5
36
NCI Comprehensive
Active Research Program
44.5
37
NCI Comprehensive
Active Research Program
44.5
38
NCI Comprehensive
Active Research Program
44.5
39
NCI Clinical
Active Research Program
44.5
40
Active Research Program
44.5
41
NCI Comprehensive
Active Research Program
44.5
42
Active Research Program
44.5
43
NCI Comprehensive
Active Research Program
44.5
44
NCI Comprehensive
Active Research Program
44.5
45
NCI Comprehensive
Active Research Program
44.5
46
NCI Clinical
Active Research Program
44.5
47
NCI Comprehensive
Active Research Program
44.5
48
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
44.5
49
Active Research Program
44.5
50
NCI Comprehensive
Active Research Program
44.5
5144.5
52
Active Research Program
44.5
53
Active Research Program
44.5
54
NCI Basic_laboratory
Active Research Program
44.5
55
Active Research Program
44.5
56
Active Research Program
44.5
57
Active Research Program
44.5
58
Active Research Program
44.5
59
Active Research Program
44.5
60
Active Research Program
44.5
61
Active Research Program
44.5
62
NCI Comprehensive
63
NCI Comprehensive
64
NCI Comprehensive
65
66
NCI Comprehensive
67
68
NCI Comprehensive
69
NCI Comprehensive
70
NCI Clinical
71
Cedars-Sinai CancerLos Angeles, CA
72
NCI Comprehensive
73
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
74

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →